FIS
AURA icon

FCPM III Services’s Aura Biosciences AURA Stock Holding History

FCPM III Services’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8M Buy
+4,053,775
New +$29M 3.84% 8

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

FCPM III Services's AURA Position: Q2 2026 in Review

FCPM III Services opened a new position in Aura Biosciences (AURA) in Q2 2026: 4,053,775 shares worth $28.8M. The stake represents 3.84% of the portfolio and ranks #8 among its holdings.

127 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • FCPM III Services held 4,053,775 shares of Aura Biosciences worth $28.8M as of Q2 2026.
  • Aura Biosciences was a new FCPM III Services position in Q2 2026.
  • Aura Biosciences made up 3.84% of FCPM III Services's portfolio in Q2 2026, its #8 holding.
  • 127 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on FCPM III Services's 13F filing for Q2 2026, filed 14 Aug 2026.